Examples of using Prolonged-release tablets in English and their translations into Croatian
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
3.15 mg prolonged-release tablets are white to off-white and of oval shape.
62 mg i 3, 15 mg tablete s produljenim oslobađanjem su bijele do gotovo bijele boje i ovalnog oblika.90 or 100 prolonged-release tablets, in a box.
3.15 mg prolonged-release tablets are white to off- white
62 mg i 3, 15 mg tablete s produljenim oslobađanjem su bijele do gotovo bijele bojeBlister(OPA/Alu/desiccant/PE-Alu foil): 21 prolonged-release tablets 3 blisters of 7 tablets. .
Blister(OPA/Al/desikant/PE-Al folija): 21 tableta s produljenim oslobađanjem 3 blistera sa po 7 tableta.If you have kidney disease, your doctor may advise you to take the usual starting dose of 0.26 mg prolonged-release tablets only every other day for the first week.
Ako imate oštećenje bubrega, liječnik Vam može preporučiti uobičajenu početnu dozu od 0, 26 mg tableta s produljenim oslobađanjem tek svaki drugi dan tijekom prvog tjedna.The maximum plasma concentrations occur at about 6 hours after administration of MIRAPEXIN prolonged-release tablets once daily.
Maksimalne koncentracije u plazmi se javljaju oko 6 sati nakon primjene MIRAPEXIN tableta s produljenim oslobađanjem jedanput dnevno.There are no data available on interchangeability for 400 mg prolonged-release tablets and 100 mg prolonged-release tablets.
Nisu dostupni podaci o međusobnoj zamjenjivosti 400 mg tableta s produljenim oslobađanjem i 100 mg tableta s produljenim oslobađanjem.50 mg and 100 mg prolonged-release tablets are available.
više godina starosti, dostupne su 50 mg i 100 mg tablete s produljenim oslobađanje.After switching to MIRAPEXIN prolonged-release tablets, the dose may be adjusted depending on the patient's therapeutic response see section 5.1.
Nakon prijelaza na MIRAPEXIN tablete s produljenim oslobađanjem, doza se može podesiti prema terapijskom odgovoru bolesnika vidjeti dio 5.1.MIRAPEXIN prolonged-release tablets is a specially designed tablet from which the active ingredient is gradually released,
MIRAPEXIN tablete s produljenim oslobađanjem posebno su oblikovane Prolonged-release tablets are not suitable for the 14-day lead-in phase for patients starting nevirapine.
Tablete s produljenim oslobađanjem nisu prikladne za 14-dnevnu uvodnu fazu za bolesnike koji počinju terapiju nevirapinom.Patients already taking MIRAPEXIN tablets may be switched to MIRAPEXIN prolonged-release tablets overnight, at the same daily dose.
Bolesnici koji već uzimaju MIRAPEXIN Take MIRAPEXIN prolonged-release tablets only once a day and each day at about the same time.
Uzimajte MIRAPEXIN tablete s produljenim oslobađanjem jedanput dnevno i to svaki dan u otprilike isto vrijeme.Patients already taking Oprymea tablets may be switched to Oprymea prolonged-release tablets overnight, at the same daily dose.
Bolesnici koji već uzimaju Oprymea The 1 mg prolonged-release tablets are round and white, hard tablets, debossed with 1MG on one side
Tablete s produljenim oslobađanjem od 1 mg okrugle su, bijele, tvrde Posology Ranexa is available as 375 mg, 500 mg, and 750 mg prolonged-release tablets.
Ranexa je na raspolaganju u obliku tableta s produljenim oslobađanjem od 375 mg, 500 mg i 750 mg.The prolonged-release tablets are approximately 7 mm in diameter,
Tablete s produljenim oslobađanjem imaju približan promjer od 7 mm,Posology Ranexa is available as 375 mg, 500 mg, and 750 mg prolonged-release tablets.
Ranexa je dostupna u obliku tableta s produljenim oslobađanjem od 375 mg, 500 mg i 750 mg.The prolonged-release tablets are approximately 7 mm in diameter,
Tablete s produljenim oslobađanjem imaju promjer oko 7 mm,Ranexa is available as 375 mg, 500 mg, and 750 mg prolonged-release tablets.
Ranexa je dostupna u obliku tableta s produljenim oslobađanjem od 375 mg, 500 mg i 750 mg.
